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Two distinct envelope fusion proteins (EFPs) (GP64 and F) have been identified in members of the Baculoviridae
family of viruses. F proteins are found in group II nucleopolyhedroviruses (NPVs) of alphabaculoviruses and in
beta- and deltabaculoviruses, while GP64 occurs only in group I NPVs of alphabaculoviruses. It was proposed that
an ancestral baculovirus acquired the gp64 gene that conferred a selective advantage and allowed it to evolve into
group I NPVs. The F protein is a functional analogue of GP64, as evidenced from the rescue of gp64-null Autographa
californica multicapsid nucleopolyhedrovirus (MNPV) (AcMNPV) by F proteins from group II NPVs or from
betabaculoviruses. However, GP64 failed to rescue an F-null Spodoptera exiguaMNPV (SeMNPV) (group II NPV).
Here, we report the successful generation of an infectious gp64-rescued group II NPV of Helicoverpa armigera
(vHaBacF-gp64). Viral growth curve assays and quantitative real-time PCR (Q-PCR), however, showed substan-
tially decreased infectivity of vHaBacF-gp64 compared to the HaF rescue control virus vHaBacF-HaF. Electron
microscopy further showed that most vHaBacF-gp64 budded viruses (BV) in the cell culture supernatant lacked
envelope components and contained morphologically aberrant nucleocapsids, suggesting the improper BV envel-
opment or budding of vHaBacF-gp64. Bioassays using pseudotyped viruses with a reintroduced polyhedrin gene
showed that GP64-pseudotyped Helicoverpa armigera single nucleocapsid nucleopolyhedrovirus (HearNPV) signif-
icantly delayed the mortality of infected H. armigera larvae.
The envelope fusion protein (EFP) of budded viruses (BV)
(30) of baculoviruses is critical for virus entry (attachment and
fusion) and egress (assembly and budding) (7, 13, 21). Two
types of BV EFPs have been identified in the Baculoviridae
family of viruses. The F proteins are similar in structure, but
they are very diverse in their amino acid sequences (20 to 40%
identity). They are widespread within the baculovirus family
(group II NPVs of the alphabaculoviruses and in beta- and
deltabaculoviruses) (23) and are thought to be carried by an-
cestral members (26). In contrast, the baculovirus GP64 ho-
mologs are all closely related EFPs (74% sequence identity)
and found only in group I NPVs of the alphabaculoviruses
(23). It has been suggested that a gp64 gene was acquired
relatively recently by an ancestral virus of the group II NPV,
thereby giving these viruses a selective advantage and obviating
the need of the envelope fusion function of the F protein (23).
A nonfusogenic F homolog (F-like protein), however, is main-
tained in the genome of group I NPVs, functioning as a viru-
lence factor (9, 17, 24, 32).
GP64 and F proteins play similar roles during the baculovi-
rus infection processes, such as virus-cell receptor attachment,
membrane fusion, and efficient budding. However, there are
striking differences between the receptor usage of GP64 and F
proteins as well. These two types of proteins are very different
in structure, mode of action, and receptor exploitation. The
crystal structure reveals that GP64 belongs to class III viral
fusion proteins, with its fusion loop located in the internal
region of the protein, and proteolytic cleavage is not required
for activation of fusion activity (10). F proteins by contrast
share common features of class I viral fusion proteins (12). The
proteolytic cleavage of the F precursor (F0) by a furin-like
protease generates an N-terminal F2 fragment and a C-teminal
F1 fragment. This cleavage is essential for exposing the N-
terminal fusion peptide of F1 and for activating F fusogenicity
(8, 36). Although the nature of the baculovirus host cell recep-
tors is still enigmatic, it has been reported that Autographa
californica multicapsid nucleopolyhedrovirus (MNPV)
(AcMNPV)) and Orgyia pseudotsugata MNPV (OpMNPV),
both using GP64 as their EFPs, exploit the same insect cell
receptor, while Lymantria dispar MNPV (LdMNPV) with an F
protein as the EFP utilizes a cell receptor different from that
used by AcMNPV (7, 37). Additionally, in the case of
SeMNPV, using competition assays, it was confirmed that the
baculovirus F protein and GP64 recognized distinct receptors
to gain entry into cultured insect cells (34).
Pseudotyping viral nucleocapsid with heterologous EFPs to
form pseudotype virions is a valuable approach to studying the
structure, function, and specificity of heterologous EFPs. It has
been a successful strategy to expand or alter viral host range,
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i.e., in gene delivery (3). For example, vesicular stomatitis virus
G (VSV-G)-pseudotyped lentivirus and AcMNPV gp64-
pseudotyped HIV-1 exhibit high virus titers and wider tropism
(5, 14, 38); the gp64-pseudotyped human respiratory syncytial
virus (HRSV) lacking its own glycoproteins is of high and
stable infectivity (22); furthermore, pseudotyped lentiviruses
with modified fusion proteins of GP64 with targeting peptides
(i.e., hepatitis B virus PreS1 peptide, involved in viral attach-
ment) or with the decay accelerating factor (DAF) facilitate
the targeting to specific cell types or confer stability against
serum inactivation, respectively (6, 19). For the Baculoviridae,
a series of pseudotyping studies have investigated the func-
tional analogy between GP64 and F proteins. F proteins of
group II NPVs (SeMNPV, LdMNPV, and Helicoverpa ar-
migera single nucleocapsid nucleopolyhedrovirus [HearNPV])
can substitute for GP64 in gp64-null AcMNPV viruses (15, 16).
Recent studies indicated that many granulovirus (GV) F pro-
teins, but not F protein from Plutella xylostella GV (PxGV), can
rescue a gp64-null AcMNPV (16, 39). These results demon-
strated that baculovirus F proteins are functional analogues to
GP64. Since it was postulated that GP64 was captured by a
baculovirus during evolution (24), one would expect the func-
tional incorporation of GP64 into the BV of an F-null group II
NPV. However, the reverse substitution of a group II NPV
(SeMNPV) F protein by GP64 failed to produce infectious
progeny viruses (35).
In this paper, we show that AcMNPV gp64 could be inserted
into an F-null HearNPV genome and produce infectious prog-
eny virus upon transfection of insect cells. The infectivity of the
pseudotyped virus, however, was greatly impaired, and large
amounts of morphologically defective BV were produced. Bio-
assay experiments indicated that the infectivity of GP64-
pseudotyped F-null HearNPV for insect larvae was not re-
duced, but that the time to death was significantly delayed.
These results demonstrate that GP64 alone can only partially
complement HearNPV F protein function.
MATERIALS AND METHODS
Insect cells and viruses. HzAM1 cells were cultured at 27°C in Grace’s insect
medium (Gibco-BRL), pH 6.0, supplemented with 10% fetal bovine serum
(FBS). The F-null HearNPV bacmid (HaBacF) and the HaF-repaired virus
vHaBacF-HaF used in this study as positive and negative controls, respectively,
were constructed and described previously (33).
Construction of recombinant bacmids. The AcMNPV gp64 gene was amplified
from AcBacmid (bMON14272) with primers gp64-For, 5-AAGCTTGCCTCA
ATGCTACTAGTAAATC-3 (HindIII site underlined), and gp64-Rev, 5-AAG
CTTGTGAGTTCAAGTCTCGCC-3 (HindIII site underlined), using Pyrobest
DNA polymerase (Takara Bio, Inc., Japan). The PCR product was extended by
an A tail by Taq DNA polymerase (Biostar, China), then cloned into a pGEM-T
easy vector (Promega), and sequenced. The gp64 gene was cloned downstream of
the Op166 promoter of pFB-Op166 (33) into the HindIII site to obtain the
transfer vector pFB-Op166-gp64. To reintroduce polyhedrin (ph) into the recom-
binant bacmids, the Op166-HaF and Op166-gp64 cassettes were digested from
pFB-Op166-HaF (33) or pFB-Op166-gp64 and further cloned into the poly-
hedrin gene-containing pFBD-ph vector (27), generating pFB-Op166-HaF-ph
and pFB-Op166-gp64-ph, respectively. Each individual transfer vector was trans-
posed into the attTn7 integration site of HaBacF, according to the Bac-to-Bac
manual (Invitrogen). Recombinant bacmids were selected by gentamicin resis-
tance and their sequences confirmed at the insertion loci by PCR as described
previously (33).
Transfection-infection assay of recombinant viruses. One microgram of each
recombinant bacmid was transfected into 1  106 HzAM1 cells using 10 l
Lipofectin (Invitrogen), according to the Bac-to-Bac manual (Invitrogen). At 6
days posttransfection (p.t.), 1 ml of the supernatant from HaBacF-HaF-trans-
fected cells (noted as passage 0 [P0]) was clarified for 10 min at 3,000  g and
used to infect a new batch of HzAM1 cells (noted as P1). Since the titer of the
progeny viruses produced from HaBacF-gp64-transfected cells was very low,
the transfected cells plus supernatant (P0) were transferred to a new flask at 6
days p.t. and passaged two more times to accumulate and achieve a relatively
high virus titer. After these 2 passages, 1 ml of the supernatant (noted as P2) was
used to infect a new batch of HzAM1 cells (P3) and so on. The supernatants
collected after passage 5 were used for experiments. At 72 h p.t. or postinfection
(p.i.), transfected or infected cells were inspected by fluorescence microscopy for
the presence of green fluorescent protein (GFP).
Western blot analysis of recombinant viruses. The expression of GP64 or F
proteins and their incorporation into BV were examined by Western analysis.
For generating anti-GP64 antibody, a fragment (218 amino acids [aa] to 457 aa)
of the gp64 gene was amplified by PCR with primers GP64C-for, 5-CCCGAA
TTCGCTTCACCACGCGCCAAATAAAA-3 (EcoRI site underlined),
and GP64C-rev, 5-CCCAAGCTTTTACTTGGTGTTCTCCATGGTGG-3
(HindIII site underlined). The PCR products were cloned into a pGEX-KG
expression vector. The proteins were purified and then used to immunize a rabbit
for generating polyclonal antiserum against GP64 as described previously (33).
Western analysis was performed using polyclonal antibodies against HaF1
(33), against GP64, or against VP80 (4) to probe sediment BV from supernatants
of infected cells. Briefly, BV were disrupted in 6 SDS-PAGE sample buffer,
and approximately 10 g of BV proteins were separated by 12% SDS-PAGE and
subjected to Western blot analysis. The antisera were used at a 1:1,000 dilution,
and the proteins were detected by treatment with alkaline phosphatase conju-
gated with goat anti-rabbit immunoglobulin (Sigma). The final signal was de-
tected by nitroblue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolylphosphate
(BCIP) (Sino-American Biotechnology Company).
Syncytium formation assay. To generate transient expression vectors contain-
ing EFP genes, a phsp70-egfp-SV40 cassette was inserted into pIZ/V5-His (In-
vitrogen) by XhoI and HindIII, generating control plasmid pIZ/V5-egfp to mon-
itor transfection. Then, the HaF and the AcMNPV gp64 genes were digested
from the pGEM-T easy vector (Promega) by HindIII, and each was subcloned
into pIZ/V5-egfp. The resulting plasmids were named pIZ/V5-HaF-egfp and
pIZ/V5-gp64-egfp, respectively.
Syncytium formation (HzAM1-HzAM1 fusion) assays were performed by
transfection with either pIZ/V5-HaF-egfp or pIZ/V5-gp64-egfp or infection with
pseudotyped virus vHaBacF-gp64 or control virus vHaBacF-HaF at a dose of
5 50% tissue culture infectious dose (TCID50) units/cell. At 48 h p.t. or p.i., cells
were washed twice with 1 ml Grace’s medium (pH 6.0) and treated for 5 min with
acidified Grace’s medium (pH 5.0). The acidic medium was removed and re-
placed with 2 ml Grace’s medium (pH 6.0) with 10% fetal bovine serum (FBS).
Syncytium formation was observed by fluorescence microscopy 24 h after treat-
ment with low-pH Grace’s medium.
Comparison of one-step growth curves of vHaBacF-gp64 and vHaBacF-
HaF. Infectious BV production was assessed by a one-step growth curve. HzAM1
cells (2  105) were infected with 5 TCID50 units/cell. At 0, 24, 48, 72, 96, and
120 h p.i., supernatants were harvested and titrated by an endpoint dilution assay.
Each virus infection was performed in triplicate. The average of the triple
log-transformed TCID50 values, and the standard deviations of the mean were
determined by using Microsoft Excel software (version 2003).
Q-PCR of recombinant viruses. Quantitative real-time PCR (Q-PCR) was
performed using Eva Green dye (Biotium, Inc.) to determine the number of
genomic DNA copies compared to viral titers, using primers lef8-For, 5-GGC
CATCCATTCGGTGAGGTC-3, and lef8-Rev, 5-CATCGTGGGCGTGGTA
GTGTC-3, for amplification of a 301-bp region of the HearNPV lef-8 gene
(GeneID 919958) using a real-time PCR detection system (Bio-Rad Opticon 2).
Supernatant (500 l) from infected cells (120 h p.i.) was incubated with 500 l
20% PEG8000 in 1 M NaCl for 30 min at room temperature (RT), and then the
virions were spun down at 12,000  g for 15 min and resuspended in 20 l H2O.
Virions were lysed by adding 80 l virus disruption buffer (10 mM Tris-HCl [pH
7.6], 10 mM EDTA, 0.25% SDS) and 5 l proteinase K (20 mg/ml). After
incubation at 50°C for 1 h, viral DNA was phenol extracted, ethanol precipitated,
and dissolved in 20 l H2O. One microliter of BV DNA was used for Q-PCR
analysis. The Q-PCR was carried out by 38 cycles at 95°C for denaturation and
at 63°C and 72°C for annealing/extension.
Electron microscopy of budded virions and polyhedron of recombinant vi-
ruses. Fresh BV from vHaBacF-HaF- or vHaBacF-gp64-infected cell super-
natants were adsorbed onto carbon-coated copper 200-mesh grids for 30 min at
room temperature. Grids were washed briefly on a large drop of ultrapure
distilled water and transferred onto a drop of negative stain (2% phosphomo-
lybdic acid, pH 6.5) for 20 s.
Polyhedra were purified 6 days p.i. from fourth-instar H. armigera larvae
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infected with vHaBacF-HaF-polh or HaBacF-gp64-polh. All samples were
processed for electron microscopy examination as described previously (31).
Specimens were examined by using an electron microscope (FEI Tecnai G2)
operated at 200 kV.
Virus competition assay. Recombinant HearNPV expressing a red fluorescent
protein (RFP) gene was constructed as a competitor virus. The RFP gene was
digested with EcoRI and NotI from pDsRed2-N1 (Clontech) and subcloned into
pFB-Op166, generating transfer vector pFB-Op166-RFP. Then the RFP gene
was transposed into HaBacHz8 to generate recombinant bacmid Ha-RFP. Fi-
nally, to produce the recombinant baculovirus vHa-RFP, the bacmid was trans-
fected according to the Bac-to-Bac manual (Invitrogen) into HzAM1 cells, and
the BV from the supernatants were stored at 4°C until use. BV of vHa-RFP were
inactivated by UV light.
HzAM1 cells (5  104) were inoculated into 24-well plates and preincubated
with increasing concentrations of UV-inactivated vHa-RFP for 1 h at 4°C.
vHaBacF-gp64 and vHaBacF-HaF (5 TCID50 units/cell) were then added to
monolayers to allow virus attachment at 4°C for 2 h. The BV-containing medium
was removed and replaced by 500 l normal medium. The infection ratios were
quantified at 24 h p.i. using a Beckman Coulter (EPICS XL) flow cytometer by
quantifying the GFP expression of infected cells at 480 nm for excitation and 520
nm for emission.
Bioassays of polyhedrin-repaired recombinant viruses vHaBacF-gp64-polh
and vHaBacF-HaF-polh. The oral infectivity of the recombinant viruses was
measured by the droplet feeding method with early third-instar H. armigera
larvae. The occlusion bodies (OBs) used for the bioassay were harvested and
purified from diseased larvae as described previously (29). Larvae were exposed
to eight concentrations: 3  106, 1  106, 3  105, 1 105, 3  104, 1 104, 3 
103, and 1  103 OBs ml1 of each. Forty-eight insects were used per each virus
concentration, and experiments were repeated twice. Median lethal concentra-
tion (LC50) values (OBs ml1) were calculated by POLO probit analysis and
compared by standard lethal dose ratio comparison (25). Median survival time
(ST50) values of the viruses (3  106 OBs ml1) were calculated using the
Kaplan-Meier estimator and further compared using a log rank test (11).
RESULTS
AcMNPV GP64 protein is able to rescue an F-null HearNPV
bacmid. An F-null HearNPV bacmid (HaBacF) and a bacmid
rescued for F (HaBacF-HaF) were previously constructed
(33) and used to generate negative- and positive-control vi-
ruses. The AcMNPV gp64 gene under the control of the
OpMNPV gp64 promoter (Op166) was inserted into
HaBacF, generating gp64-pseudotyped bacmid HaBacF-
gp64 (Fig. 1A). The correct insertions in the recombinant bac-
mids were confirmed by PCR and EcoRI digestion. In
HaBacF, a 12.2-kb EcoRI band (arrow) containing the poly-
hedrin locus is present, while two new 14.4-kb and 2.7-kb
EcoRI bands were generated due to insertion of the HaF gene
(Fig. 1B), which contains one EcoRI site (33). In HaBacF-
gp64, due to insertion of the gp64 gene, the 12.2-kb EcoRI
band changed to two bands of 14.4 kb and 2.3 kb (Fig. 1B). The
restriction profile showed that all of the bands in the recom-
binant bacmids were shifted as expected (indicated by arrow-
heads, Fig. 1B), confirming the correct insertion of the EFP
genes.
HzAm1 cells were transfected with HaBacF, HaBacF-
HaF, or HaBacF-gp64 or mock transfected. At 72 h p.t.,
GFP-positive cells were observed in a fluorescence microscope
in all plates except those that were mock transfected (Fig. 1C).
Although the HaBacF bacmid entered cells by transfection,
as evidenced from the presence of GFP-positive cells (Fig.
1C-b), infectious BV were not produced, as secondary infec-
tion could not be established and not even a single GFP-
positive cell was observed (Fig. 1C-b’). This result is in agree-
ment with previous observations that HaF is an essential gene
for HearNPV infection (33). In parallel experiments using
HaF-rescued bacmid HaBacF-HaF, fluorescence spread in
both transfected and infected cells (Fig. 1C-c and C-c’), indi-
cating that the defect in infectivity can be rescued by reintro-
ducing an HaF gene into HaBacF. Transfection with
pseudotyped bacmid HaBacF-gp64 also resulted in primary
as well as in secondary infections (Fig. 1C-d), as evidenced by
infecting a new batch of HzAM1 cells using supernatants from
passage 5 (Fig. 1C-d’). Thus, gp64 is able to rescue an F-null
HearNPV bacmid. It is necessary to point out that the infec-
tious progeny BV of pseudotyped virus vHaBacF-gp64 were
not always produced in each independent transfection assay
(1 positive per 6 transfections). Successful transfection and
BV production seemed to depend on both optimal cell condi-
tions and high transfection efficiency and require further opti-
mization of the system.
The expression and fusogenic ability of GP64 in
pseudotyped virus. Diagnostic PCR (data not shown) and
Western blot analyses of purified virions were conducted to
confirm the correct assembly of recombinant BV. Anti-GP64
antiserum detected a band corresponding to the predicted
molecular mass of GP64 (64 kDa) in vHaBacF-gp64 BV
(Fig. 2A, left, lane 1), but not in vHaBacF-HaF BV (Fig. 2A,
left, lane 2). Anti-HaF1 antiserum detected a major band (59
kDa) of the cleaved HaF1 subunit and a minor band (80
kDa) of uncleaved F0 precursor only in vHaBacF-HaF BV
(Fig. 2A, middle, lane 2) (15, 33) but not in vHaBacF-gp64
BV (lane 1). The antibody against nucleocapsid protein VP80
(80 kDa) was used as an internal control for the presence of
equal amounts of BV proteins in each lane (Fig. 2A, right).
Thus, Western analysis confirmed the correct expression and
incorporation of GP64 into pseudotyped HearNPV BV.
Viral-cell membrane fusion is a key step for delivering the
viral genetic material into the cytoplasm of the host cell. Both
baculovirus GP64 and F protein are low-pH-triggered mem-
brane fusion proteins (1, 23, 36). In order to examine the
fusogenic ability of GP64 for HzAM1 cells, syncytium forma-
tion assays were conducted as described in Materials and
Methods. When vHaBacF-HaF-infected cells were treated
with low pH, multinuclear cells were observed (Fig. 2B-b and
B-b’), which was consistent with the previous findings that HaF
can cause cell fusion (33). Meanwhile, vHaBacF-gp64-in-
fected cells exposed to low-pH syncytium formation was im-
mediately (5 min) detected (data not shown). Twenty-four
hours later, stable syncytia were observed, and both the scale
and size of multinuclear cells resulting from vHaBacF-gp64
infection were remarkably larger (Fig. 2B-d and B-d’) than
those induced by vHaBacF-HaF (Fig. 2B-b and B-b’). Similar
results were found in the transient transfection assays by using
a plasmid expressing GP64 or HaF protein under the control of
the immediate early promoter IE1 (Fig. 2C). These results
confirmed that the membrane fusion capability of GP64 is
higher than that of HaF protein in HzAM1 cells and reflects
the high fusogenic ability of GP64 (1).
GP64 pseudotyping leads to less-infectious recombinant
HearNPV BV. To characterize the effect of gp64 pseudotyping
on HearNPV BV production, one-step growth assays were
carried out and the curves compared between vHaBacF-gp64
and vHaBacF-HaF (Fig. 3). HzAM1 cells were infected with
vHaBacF-HaF or vHaBacF-gp64 with 5 TCID50 units/cell,
and BV production was measured at different time points p.i.
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by an endpoint dilution assay. The results showed that the two
viruses had very different BV production kinetics. The lag
phase of vHaBacF-gp64 BV production (0 to 48 h p.i.) was
much longer than that of vHaBacF-HaF (0 to 12 h p.i.) (33).
All through the log phase and the stationary phase, the infec-
tious BV production of vHaBacF-HaF was about 1 or 2 log
units higher than that of vHaBacF-gp64 (Fig. 3). At 120 h p.i.,
the BV titer of vHaBacF-HaF was 2.53 	 0.92  106 TCID50
units ml1, while the BV titer of vHaBacF-gp64 was only
7.90 	 1.39  104 TCID50 units ml
1, almost 32 times lower
than that for vHaBacF-HaF. Thus, the insertion of gp64 into
F-null HearNPV leads to a significant reduction in infectious
BV production compared to vHaBacF-HaF.
To further investigate whether the reduced infectious BV
production of vHaBacF-gp64 was due to a lower BV yield or
a lower infectivity, quantitative Q-PCR was performed using
BV samples at 120 h p.i. from a one-step growth curve assay.
The results showed that for vHaBacF-HaF, one TCID50 unit
was equivalent to 5.4  104 copies of viral genomic DNA
(Table 1), whereas for gp64-pseudotyped virus, vHaBacF-
gp64, one TCID50 unit was equivalent to 2.8  10
5 copies of
viral genomic DNA (Table 1). Hence, the infectious virus per
FIG. 1. Construction and transfection-infection assay of recombinant bacmids. (A) Schematic representative genomes of F-null bacmid
HaBacF, HaF-rescued bacmid HaBacF-HaF, or gp64-pseudotyped bacmid HaBacF-gp64. pOp166, OpMNPV fusion protein (ORF126)
promoter; pPolh, AcMNPV polyhedrin promoter; SV40, simian virus 40 terminator. (B) Identification of the parental (HaBacHZ8) and
recombinant bacmids by EcoRI digestion. M1, DL2000 DNA ladder; M2, 
 DNA digested by HindIII plus BamHI plus EcoRI. Shifted bands are
indicated by arrowheads (original bands with open arrowheads and shifted bands with white solid arrowheads). The sizes of the molecular weight
markers (in thousands) are indicated on the right. (C) Transfection-infection assay. HzAM1 cells were transfected with the indicated bacmids (b,
c, and d) or mock treated (a). At 6 days p.t., supernatants from the mock-, HaBacF-, and HaBacF-HaF-transfected cells (P0) were used to infect
healthy HzAM1 cells (P1) (panels a’, b’, and c’). For vHaBacF-gp64, supernatant from P5 was used to infect healthy HzAM1 cells (d’). The cells
were observed by fluorescence microscopy at 3 days p.t. or p.i.
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FIG. 2. Detection of GP64 expression and fusogenicity. (A) Western blot analyses of envelope protein in recombinant BV. Virions were
harvested and purified from the supernatants of infected HzAM1 cells at 6 days p.i., and the proteins were separated by SDS-PAGE. The blots
were probed with antibodies against GP64 (left), HaF1 (middle), and VP80 (right). Lanes: 1, HaBacF-gp64 BV; 2, vHaBacF -HaF BV; M, the
protein marker with indicated molecular mass. (B) Syncytium formation assay of HzAM1 cells infected by recombinant viruses. HzAM1 cells were
infected with vHaBacF-HaF or vHaBacF-gp64 at 5 TCID50 units/cell. At 48 h p.i., cells were incubated with Grace’s insect medium at pH 6.0
(a and c) or 5.0 (b and d) for 5 min. Syncytium formation was examined by fluorescence microscopy 24 h after dropping the pH. Images in panels
a to d were taken under UV light, and panels a’ to d’ show the same fields as those shown in a to d under white light, respectively. Multinuclear
cells are indicated by arrows. (C) Cell-to-cell fusion of HzAM1 cells transfected with plasmids containing the gp64 or HaF gene. Cells were
transfected with 10 g of plasmid pIZ/V5-HaF-egfp or pIZ/V5-gp64-egfp or a control plasmid, pIZ/V5-egfp. At 48 h p.t., cells were treated for
5 min with Grace’s insect medium at pH 6.0 (a, b, and c) or 5.0 (d, e, and f) for 5 min. Syncytium formation were scored by fluorescence microscopy
24 h after dropping the pH. Images shown in panels a to f were taken under UV light, and panels d’ to f’ show the same fields as those shown in
panels d to f under white light, respectively. Multinuclear cells are indicated by arrows.
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particle ratio of vHaBacF-gp64 is about five times lower than
that of vHaBacF-HaF. The infectious BV production of
vHaBacF-gp64 is about 32 times lower than that of
vHaBacF-HaF (Fig. 3). If taking into account the TCID50/BV
genome ratio, then the total vHaBacF-gp64 BV yield in terms
of BV genome copies was reduced about 6-fold.
GP64-pseudotyped virus vHaBacF-gp64 exhibits markedly
defective BV morphology. Viral envelope proteins have been
proposed to play important roles in the processes of assembly,
morphogenesis, budding, and release of progeny virus at the
cell surface. To determine whether GP64-pseudotyped
HearNPV BV had an altered morphology, transmission elec-
tron microscopy was used to compare virions of vHaBacF-
gp64 with those from the control virus, vHaBacF-HaF (Fig.
4). To fully preserve the integrity of the virion structure and
avoid influence of ultracentrifugation on BV morphology, su-
pernatants from vHaBacF-gp64- or vHaBacF-HaF-infected
cells were observed directly by electron microscopy. We found
a remarkable difference between vHaBacF-HaF BV and
vHaBacF-gp64 BV in virion structure integrity. Most
(90%) of the vHaBacF-HaF BV consisted of enveloped
rod-shaped particles (Fig. 4A and B), with sometimes a cap-
like structure (Fig. 4A, indicated by black arrows) near one end
of the rod-shaped nucleocapsid and with an extension in the
other end (Fig. 4A, white arrows). These characteristics were
typical of wild-type HearNPV BV as well, under these condi-
tions (data not shown). In contrast, very few of the vHaBacF-
gp64 BV consisted of enveloped rod-shaped particles (Fig.
4C). It was clearly visible that most (95%) of the vHaBacF-
gp64 virions lacked an envelope and appeared like nucleocap-
sids (Fig. 4D to F). These nucleocapsids could be greater
(ranging from approximately 800 nm to 1,200 nm) (Fig. 4E) in
length than the virions of vHaBacF-HaF (around 400 nm)
(Fig. 4A and B). Some nucleocapsids appeared distorted or
broken, with the ribonucleoprotein complex of DNA plus viral
capsid proteins protruding through the breaks of the nucleo-
capsids (Fig. 4D, triangles). Some aggregates of nucleocapsids
surrounded by membrane-like structures were also detected in
vHaBacF-gp64 preparations (Fig. 4F). These findings sug-
gested that vHaBacF-gp64 BV had an aberrant and highly
pleiomorphic appearance.
vHaBacF-gp64 utilizes the same entry component as wild-
type HearNPV to gain entry into HzAM1 cells. The cell surface
receptor is a major determinant restricting the viral host range
as well as infectivity. To investigate the receptor usage of
vHaBacF-gp64 and vHaBacF-HaF in HzAM1 cells, we con-
structed recombinant HearNPV expressing RFP (vHa-RFP) as
a competitor virus and conducted competition assays using
UV-inactivated vHa-RFP. Since the EGFP marker gene was
used by vHaBacF-gp64 and vHaBacF-HaF, the RFP marker
gene was used and cloned to the competitor virus. The UV
inactivation of the viruses was confirmed by infection assays
showing no residual infectivity (red fluorescence) after UV
treatment in HzAM1 cells but abundant intracellular red flu-
orescence when untreated viruses were used (data not shown).
As Fig. 5 indicates, both vHaBacF-gp64 and vHaBcF-HaF
were competed out by inactivated vHa-RFP in a dose-depen-
dent manner. At 100 TCID50 units/cell for vHa-RFP, the in-
fection rates of vHaBcF-HaF and HaBacF-gp64 were re-
duced to 28.9 	 3.2% and 48.6 	 3.5%, respectively. These
data suggest that in HzAM1 cells vHaBacF-gp64 binds to (or
blocks binding to) the same virus binding sites as HearNPV to
gain entry into HzAM1 cells.
GP64 delays mortality in Helicoverpa armigera larvae. Bac-
ulovirus GP64 and F proteins of group II NPVs (HearNPV,
SeMNPV, etc.) are essential for cell-to-cell spread in insect cell
culture and within infected larvae. In order to determine the
effects of GP64 expression on occlusion-derived virus (ODV)
morphology and infectivity in vivo, polh and gp64, or polh
and HaF, were reintroduced into HaBacF by transposition
(Fig. 6A). The resulting bacmids HaBacF-gp64-polh and
HaBacF-HaF-polh were confirmed by PCR (data not
shown). Infectious progeny BV were produced after transfec-
tion of recombinant bacmids into HzAM1 cells, which were
then characterized by detection of GFP and the appearance of
OBs in infected cells (Fig. 6B). To study OB morphology of
pseudotyped virus, polyhedra were purified from vHaBacF-
gp64-polh- or vHaBacF-HaF-polh-infected larvae and in-
spected by electron microscopy. OBs of vHaBacF-gp64-polh
had shapes and sizes similar to those of vHaBacF-HaF-polh
(Fig. 6C); also, the numbers of ODVs and their distributions
and relative proportions per OB were very similar. This indi-
cated that the swapping of BV EFPs had no impact on the
formation and morphology of OBs.
To study the oral infectivity of recombinant viruses, third-
FIG. 3. One-step growth curve assays of recombinant viruses. HzAm1
cells were infected with vHaBacF-HaF or vHaBacF-gp64 at 5 TCID50
units/cell. BV titers at different time points (h p.i.) were quantified by
endpoint dilution assays. Each data point represents the average value
from three separate infections. Error bars, standard deviations.
TABLE 1. Q-PCR to determine viral genomic DNA copies compared to infectious BV titers
Recombinant virus
(120 h p.i.)
DNA copies determined by





(no. of copies per
TCID50 unit)
vHaBacF-HaF 1.37 	 0.27  1011 2.53 	 0.92  106 5.42 	 0.41  104
vHaBacF-gp64 2.18 	 0.36  1010 7.90 	 1.39  104 2.76 	 0.24  105
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instar H. armigera larvae were infected with eight OB concen-
trations of vHaBacF-gp64-polh or vHaBacF-HaF-polh (Ta-
ble 2). Standard lethal dose ratio comparison (25) indicates
that there is no significant difference between the infectivity of
these two viruses, as the 95% confidence limits (CL) of the
potency ratio, which is the ratio of the relative infectivity of
pseudotyped virus to that of the control virus, include the value
1.0 in both assays. Meanwhile, the LC50s of the two recombi-
nant viruses on third-instar larvae are similar to that of wild-
type (wt) HearNPV, which is about 3.1  104 OBs ml1 (28).
Therefore, GP64 pseudotyping did not affect the LC50 (infec-
tivity per OB) of HearNPV. However, insects fed with
pseudotyped virus vHaBacF-gp64-polh exhibited a significant
delay in mortality (Table 2). Larvae orally infected with a
concentration of 3  106 OBs ml1 of vHaBacF-gp64-polh
showed 50% mortality at approximately 114 h p.i., and the
calculated 50% survival time (ST50) value was 132 h, while the
control virus vHaBacF-HaF-polh showed 50% mortality at
about 92 h p.i. and the ST50 value was approximately 108 h
(Table 2). The statistical analysis indicated that there was a
significant difference (P  0.01) in the ST50 values between
vHaBacF-gp64-polh and vHaBacF-HaF-polh (Table 2).
Thus, GP64-pseudotyped HearNPV delayed the mortality of
the host insect H. armigera by about 24 h.
DISCUSSION
Baculovirus F proteins are functional analogues to GP64, as
evidenced from the rescue of gp64-null AcMNPV by F proteins
from group II NPVs or betabaculoviruses (16, 39). However,
FIG. 4. Electron micrographs of control vHaBacF-HaF BV or pseudotyped vHaBacF-gp64 BV. (A) Virions of vHaBacF-HaF BV.
(B) Higher-magnification image of the boxed region in panel A. (C) Intact virions of vHaBacF-gp64 BV. (D to F) Broken, extended, or
aggregated nucleocapsids of vHaBacF-gp64 BV. Black arrows, cap-like structure; white arrows, extension structure; open triangles, nucleoprotein
extrusions.
FIG. 5. Competition assay using inactivated vHa-RFP. HzAm1
cells were preincubated with increasing amounts of UV-inactivated
vHa-RFP for 1 h, and then infected with vHaBacF-HaF or
vHaBacF-gp64 at 5 TCID50 units/cell. The infection rates were
quantified at 24 h p.i. by flow cytometry. Data points represent the
average value from triplicate infections. Error bars, standard devi-
ations of the mean. The blot below the figure represents Western
analysis of UV-inactivated vHa-RFP, which was used in the com-
petition assay, probed by antibody against HaF1. M, the protein
marker.
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GP64 failed to conversely rescue an F-null SeMNPV (group II
NPV) in many transfection trials (35). Since the virus back-
bones (SeMNPV in the previous study and HearNPV in this
study) taken for these substitution assays are different, there
are many possible reasons that could have led to the different
results, including (i) a rate of transfection of the SeMNPV
bacmid into Se301 cells (35) that is lower (0.1%) than that of
the HearNPV bacmid into HzAM1 cells (0.1 to 1%), (ii) a
lower compatibility of GP64 with SeMNPV viral proteins, or
(iii) a lower affinity of the Se301 cellular receptor with GP64.
In this study, it is also very difficult to generate infectious
pseudotyped virus vHaBacF-gp64 since the virus titers in the
early passages (P1 to P3) are very low (10
3 TCID50 units/ml).
The virus titer can finally reach approximately 5  105 TCID50
units/ml after 5 cell passages. However, once the infectious
pseudotyped virus vHaBacF-gp64 is propagated to a high
level, it can be passaged continuously in cell culture and can be
lethal to H. armigera larvae. Thus, this study is the first suc-
cessful attempt to pseudotype a group II NPV by GP64 (group
I NPV) in the absence of an authentic group II F protein (Fig.
1 and 2) and demonstrate that GP64 can, in principle, partially
compensate for essential functions of F protein.
During virus propagation in HzAM1 cells, we observed that
the F-null HearNPV pseudotyped with AcMNPV GP64
(vHaBacF-gp64) spread from cell to cell but at a lower rate
and generated substantially lower virus titers than control virus
FIG. 6. Construction of polh-reintroduced recombinant viruses. (A) Schematic representation of polh-reintroduced viruses vHaBacF-HaF-
polh or vHaBacF-gp64-polh. (B) Fluorescence (top) and bright-field (bottom) images of HzAM1 cells transfected with HaBacF-HaF-polh (a)
or HaBacF-gp64-polh (b) and analyzed at 5 days p.t. Cells containing OBs are indicated by arrows (a’ and b’). (C) Electron microscopy of OB
morphology. Purified OBs from H. armigera larvae deceased after infection with vHaBacF-HaF-polh or vHaBacF-gp64-polh. V, virions; PE,
polyhedron envelope.
TABLE 2. Bioassays of the recombinant viruses in third-instar H. armigera larvae









1 vHaBacF-gp64-polh 0.53 (0.35–0.78) 0.42 (0.17–1.02) 132 	 3.17 0.01
vHaBacF-HaF-polh 1.26 (0.83–1.93) 108 	 1.63
2 vHaBacF-gp64-polh 1.23 (0.73–2.15) 0.99 (1.61–3.59) 132 	 1.47 0.01
vHaBacF-HaF-polh 1.24 (0.89–1.76) 108 	 0.00
a LC50s were calculated using the POLO probit analysis program and reported with 95% confidence limits (CL). For each treatment, LC50s were not significantly
different. Significant difference was determined based on whether the 95% CL of the potency ratio included the value 1.0 (25). Potency ratio equal to LC50 of the
pseudotyped virus vHaBacF-gp64 divided by the LC50 of the control virus vHaBacF-HaF (25). PIBs, polyhedral inclusion bodies.
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(vHaBacF-HaF) (Fig. 1C). One-step growth curve analysis
(Fig. 3) showed that the overall dynamics of vHaBacF-gp64
infection (viruses from P5) were much slower than those of
vHaBacF-HaF (viruses from P2), with an approximately 30-
to 50-fold decrease in infectious BV production for the former
virus, but in the early passages the reduction could be as high
as 104-fold. In most other pseudotyping cases within the Bacu-
loviridae family, the pseudotyped BV titers were reduced but
often less (10-fold) than those for the wild-type phenotype
(16). The vesicular stomatitis virus G (VSV-G) protein was
able to complement the deletion of GP64 in AcMNPV, but the
detection of infectious BV was 1 to 10% of that detected from
wild-type AcMNPV (18); the SeMNPV F protein was also
demonstrated to functionally complement F-null HearNPV,
and the titer of pseudotyped virus vHaBacF-SeF also de-
creased up to 10-fold (33). These examples reflect a reduced
degree of compatibility between heterologous EFPs with alter-
nate baculovirus vectors and host cells. It remains to be tested
whether GP64 can be used to pseudotype other group II NPVs,
in particular those of more distantly related species, with a
similar reduction in titer and delay in infection characteristics.
Viral EFPs are not only important for BV infectivity, but
also for BV morphogenesis and egress. In the case of VSV-G-
pseudotyped AcMNPVgp64, gp64-pseudotyped HRSV lack-
ing G, F, and SH protein (HRSVSH,G,F), and VSV G-
pseudotyped HIV, the virion structure seems to be similar to
those of wild-type viruses, as they are morphologically indis-
tinguishable (18, 22). In contrast, although gE and gM are not
essential for herpesvirus replication, simultaneous deletion of
both envelope genes drastically inhibits virion envelopment in
the trans-Golgi area (2, 20). Electron microscopy results re-
vealed that gp64-pseudotyped HearNPV exhibits aberrant BV
morphology, with abundant extended or broken nucleocapsids
lacking a detectable envelope (Fig. 4E and F). This could be
the result of improper envelopment of HearNPV nucleocap-
sids or an unstable envelope directed by GP64 or lack of F.
Nevertheless, we did find GP64 in virion preparations (Fig.
2A), but their distribution over the virions may be erratic or
clustered in membrane vesicles carrying multiple nucleocap-
sids (Fig. 4F). We therefore infer that there is a direct corre-
lation between abnormal virion morphology and reduced in-
fectivity, most likely as a result of abortive infections by most of
these morphologically defective virions.
The OB morphology of vHaBacF-gp64-polh is similar to
that of vHaBacF-HaF-polh, indicating gp64 pseudotyping did
not have any obvious impact on the expression and trafficking
of polyhedron-associated proteins in the assembly process
(Fig. 6C). This underscores the independence of the ODV
occlusion process and BV assembly. The bioassay results con-
firmed this view, as gp64 pseudotyping did not alter the mor-
phology of OBs and the LC50 of the virus (Table 2). However,
the pseudotyping of HearNPV with GP64 did increase the
ST50 of the infected larvae significantly (Table 2). Similarly,
deletion of the F-like protein (Ac23) in AcMNPV results in
not only a significant delay in ST50 but also a 100-fold decrease
in BV production of gp64null AcMNPV pseudotyped with SeF
without affecting BV formation and infectivity (17, 32). We
assume that the delayed killing of infected larvae is due to the
decreased infectivity of gp64-pseudotyped HearNPV BV,
which may be the consequence of reduced HearNPV intercel-
lular spread from midgut epithelial cells to other cell types and
beyond, thereby reducing the overall speed of virus propaga-
tion within infected insect larvae.
In summary, in this study we successfully generated a gp64-
pseudotyped F-null HearNPV and extensively analyzed its bi-
ological properties and morphologies. The fusogenic ability of
GP64 for HzAM1 cells is found to be higher than that of the F
protein. However, on account of the decreased infectivity and
defective virion morphology, we conclude that gp64 can only
partially substitute for the F protein in HearNPV, leading to
the production of partially defective virions. The evolution
hypothesis suggests that an ancestral group II baculovirus cap-
tured an ancestral gp64 gene, which allowed higher fusogenic-
ity and led to the rapid divergence and evolution of group I
NPVs (24, 26). In this study the functional recruitment of gp64
into an F-null group II NPV provides experimental support for
this supposition. Since the substitution of an F-null HearNPV
by AcMNPV GP64 is imperfect, we propose that F proteins
possess important functions (such as mediating proper virus-
cell receptor interaction, directing efficient budding, and con-
ferring envelope stability) over those of GP64 during group II
NPV infection and morphogenesis. The preservation of a rem-
nant F (F-like) protein in group I NPVs upon the replacement
of the ancestral F with GP64 for fusogenicity indirectly sup-
ports the above hypothesis.
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